FDA

The FDA's Big Bad Wolfe
The FDA's Big Bad Wolfe
Forbes
FDA
Sidney Wolfe
Flag link:
Seattle Genetics, FDA agree on cancer study design
Seattle Genetics, FDA agree on cancer study design
Yahoo/AP
Seattle Genetics
FDA
drug trials
cancer
Flag link:
Steven Nissen Gives Obama an Rx for FDA Reform
Steven Nissen Gives Obama an Rx for FDA Reform
WSJ Online
Steven Nissen
FDA
Flag link:
FDA fails to meet Takeda drug application deadline
FDA fails to meet Takeda drug application deadline
Hays Pharma, UK
FDA
Takeda
febuxostat
Flag link:
Medical Devices Win U.S. Nod Without Proof of Safety
Medical Devices Win U.S. Nod Without Proof of Safety
Bloomberg
FDA
devices
Flag link:
Trading FDA Decisions: Cypress Bioscience Soars, A Trio of Buys
Trading FDA Decisions: Cypress Bioscience Soars, A Trio of Buys
Seeking Alpha
Cypress Bioscience
FDA
Schering Plough
Forest Labs
Savella
Saphris
Momenta
Amag Pharmaceuticals
BioDelivery Sciences
Flag link:
FDA probe finds no link with asthma drugs, suicide
FDA probe finds no link with asthma drugs, suicide
AP
FDA
asthma
Singulair
Flag link:
FDA Commissioner Decision Coming Today?
FDA Commissioner Decision Coming Today?
InVivo
FDA
Flag link:
Schering-Plough: FDA wants labels, data for Saphris
Schering-Plough: FDA wants labels, data for Saphris
Marketwatch
Schering Plough
FDA
schizophrenia
Saprhis
Flag link:
FDA declines to approve OTC heartburn drug: Santarus
FDA declines to approve OTC heartburn drug: Santarus
Reuters
FDA
heartburn
Santarus
Flag link:
FDA OKs sharing unapproved drug uses with docs
FDA OKs sharing unapproved drug uses with docs
Yahoo/AP
FDA
off-label
Flag link:
Sidney Wolfe: Outsider Becomes FDA Insider
Sidney Wolfe: Outsider Becomes FDA Insider
WSJ Online
Sidney Wolfe
FDA
Flag link:
FDA supports Vytorin use after finishing review of controversial comparison study
FDA supports Vytorin use after finishing review of controversial comparison study
Yahoo/AP
FDA
Vytorin
Merck
Schering Plough
Flag link:
FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults
FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults
Yahoo
FDA
Eli Lilly
Olanzapine
schizophrenia
Flag link:
Henney, Former FDA Chief, Being Considered by Obama
Henney, Former FDA Chief, Being Considered by Obama
Bloomberg
FDA
Jane Henney
Flag link:
2009 means new leadership
2009 means new leadership
Fierce Pharma
FDA
Flag link:
FDA says ad for Abbott's Humira downplays risks
FDA says ad for Abbott's Humira downplays risks
Reuters
FDA
Abbott Laboratories
Humira
Flag link:
AstraZeneca says FDA asks for Seroquel detail
AstraZeneca says FDA asks for Seroquel detail
Yahoo/AP
FDA
AstraZeneca
Seroquel
Flag link:
FDA Drug Approvals Inch Upward in 2008
FDA Drug Approvals Inch Upward in 2008
WSJ Online
FDA
JNJ
UCB Pharmaceuticals
Flag link:
Sneak Peek 2009: Robert Langreth On Health Care
Sneak Peek 2009: Robert Langreth On Health Care
Forbes
FDA
Genentech
Roche
GSK
JNJ
Flag link:

Pages